Skip to main content
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.750
+0.030 (1.74%)
At close: Jun 26, 2026, 4:00 PM EDT
1.760
+0.010 (0.57%)
After-hours: Jun 26, 2026, 7:43 PM EDT

Gain Therapeutics Employees

As of December 31, 2025, Gain Therapeutics had 21 total employees, including 20 full-time and 1 part-time employees. The number of employees decreased by 4 or -16.00% compared to the previous year.

Employees
21
Change (1Y)
-4
Growth (1Y)
-16.00%
Revenue / Employee
n/a
Profits / Employee
-$1,011,418
Market Cap
74.64M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202521-4-16.00%
Dec 31, 202425-7-21.88%
Dec 31, 20233213.23%
Dec 31, 20223126.90%
Dec 31, 20212915107.14%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Related Stocks

Company Name Employees
Heron Therapeutics 128
MindWalk Holdings 102
XBiotech 87
Acrivon Therapeutics 76
Pliant Therapeutics 49
Elicio Therapeutics 33
Entera Bio 22
iBio, Inc. 20
Employee Rankings

GANX News

More News